Bansi Desai
Stock Analyst at J.P. Morgan
(2.24)
# 2,988
Out of 4,355 analysts
63
Total ratings
37.2%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: BLUEJET Blue Jet Healthcare Limited | Maintained: Sell | ₹600.00 → ₹370.00 | $449.35 | -17.66% | 4 | May 27, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Maintained: Buy | ₹1,050 → ₹1,120 | $928.45 | +20.63% | 5 | May 27, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,800 → ₹7,400 | $6,667.00 | +10.99% | 2 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹2,800 → ₹2,850 | $2,375.60 | +19.97% | 6 | May 22, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Maintained: Hold | ₹1,010 → ₹1,050 | $1,077.70 | -2.57% | 4 | May 22, 2026 | |
| NSE: ANTHEM Anthem Biosciences Limited | Maintained: Buy | ₹780.00 → ₹850.00 | $759.95 | +11.85% | 3 | May 22, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Buy | ₹1,780 → ₹1,550 | $1,401.00 | +10.64% | 5 | May 18, 2026 | |
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Hold | ₹6,050 → ₹6,400 | $5,498.00 | +16.41% | 4 | Nov 13, 2025 | |
| NSE: LUPIN Lupin Limited | Maintained: Buy | ₹2,550 → ₹2,600 | $2,267.70 | +14.65% | 5 | Nov 9, 2025 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Maintained: Sell | ₹1,090 → ₹1,150 | $1,303.50 | -11.78% | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹34,500 → ₹37,000 | $26,855.00 | +37.78% | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,350 → ₹1,550 | $1,696.00 | -8.61% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,240 → ₹1,480 | $1,189.00 | +24.47% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,030 → ₹1,970 | $1,799.20 | +9.49% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,700 → ₹1,840 | $1,380.30 | +33.30% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,390 → ₹1,325 | $965.10 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹8,800 | $8,176.50 | n/a | 1 | Feb 12, 2025 |
Blue Jet Healthcare Limited
May 27, 2026
Maintained: Sell
Price Target: ₹600.00 → ₹370.00
Current: $449.35
Upside: -17.66%
Fortis Healthcare Limited
May 27, 2026
Maintained: Buy
Price Target: ₹1,050 → ₹1,120
Current: $928.45
Upside: +20.63%
Divi's Laboratories Limited
May 25, 2026
Maintained: Buy
Price Target: ₹7,800 → ₹7,400
Current: $6,667.00
Upside: +10.99%
Mankind Pharma Limited
May 22, 2026
Maintained: Buy
Price Target: ₹2,800 → ₹2,850
Current: $2,375.60
Upside: +19.97%
Zydus Lifesciences Limited
May 22, 2026
Maintained: Hold
Price Target: ₹1,010 → ₹1,050
Current: $1,077.70
Upside: -2.57%
Anthem Biosciences Limited
May 22, 2026
Maintained: Buy
Price Target: ₹780.00 → ₹850.00
Current: $759.95
Upside: +11.85%
Cipla Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,780 → ₹1,550
Current: $1,401.00
Upside: +10.64%
Alkem Laboratories Limited
Nov 13, 2025
Maintained: Hold
Price Target: ₹6,050 → ₹6,400
Current: $5,498.00
Upside: +16.41%
Lupin Limited
Nov 9, 2025
Maintained: Buy
Price Target: ₹2,550 → ₹2,600
Current: $2,267.70
Upside: +14.65%
Dr. Reddy's Laboratories Limited
Aug 19, 2025
Maintained: Sell
Price Target: ₹1,090 → ₹1,150
Current: $1,303.50
Upside: -11.78%
Aug 15, 2025
Maintained: Buy
Price Target: ₹34,500 → ₹37,000
Current: $26,855.00
Upside: +37.78%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,350 → ₹1,550
Current: $1,696.00
Upside: -8.61%
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,240 → ₹1,480
Current: $1,189.00
Upside: +24.47%
Aug 1, 2025
Maintained: Buy
Price Target: ₹2,030 → ₹1,970
Current: $1,799.20
Upside: +9.49%
Jul 29, 2025
Maintained: Buy
Price Target: ₹1,700 → ₹1,840
Current: $1,380.30
Upside: +33.30%
May 22, 2025
Maintained: Buy
Price Target: ₹1,390 → ₹1,325
Current: $965.10
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: ₹8,800
Current: $8,176.50
Upside: n/a